AKT2 and familial pancreatic carcinoma: Other targets of MIR296 are the proto-oncogenes AKT2 in pancreatic cancer (Li et al., 2017), PLK1 in non-small cell lung cancer (Xu et al., 2016), SP1 in cervical cancer (Lv and Wang, 2018) and CDX1 in gastric cancer (Li et al., 2014).